tiprankstipranks
Trending News
More News >
Lotus Bio-Technology Development Corp. (LBTD)
OTHER OTC:LBTD
US Market

Lotus Bio-Technology Development (LBTD) Income Statement

Compare
8 Followers

Lotus Bio-Technology Development Income Statement

Last quarter (Q3 2018), Lotus Bio-Technology Development's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Lotus Bio-Technology Development's net income was $-622.00. See Lotus Bio-Technology Development’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 17
Total Revenue
$ 0.00
Gross Profit
$ 0.00
Operating Expenses
$ 19.55K
Depreciation and Amortization
$ 1.09K
EBITDA
$ -19.55K
Operating Income
$ -19.55K
Other Income/Expenses
$ 0.00
Pretax Income
$ -19.55K
Net Income
$ -19.55K
Per Share Metrics
Basic EPS
$ >-0.01
Diluted EPS
$ >-0.01
Weighted Average Shares Outstanding
82.78M
Weighted Average Shares Outstanding (Diluted)
82.78M
Currency in USD

Lotus Bio-Technology Development Earnings and Revenue History